25 XP   0   0   10

Guangxi Liuzhou Pharm Co Ltd
Buy, Hold or Sell?

Let's analyse Guangxi Liuzhou Pharm Co Ltd together

PenkeI guess you are interested in Guangxi Liuzhou Pharm Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangxi Liuzhou Pharm Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guangxi Liuzhou Pharm Co Ltd

I send you an email if I find something interesting about Guangxi Liuzhou Pharm Co Ltd.

Quick analysis of Guangxi Liuzhou Pharm Co Ltd (30 sec.)










What can you expect buying and holding a share of Guangxi Liuzhou Pharm Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.53
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥17.57
Expected worth in 1 year
¥23.77
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥10.03
Return On Investment
43.8%

For what price can you sell your share?

Current Price per Share
¥22.89
Expected price per share
¥19.74 - ¥25.22
How sure are you?
50%

1. Valuation of Guangxi Liuzhou Pharm Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥22.89

Intrinsic Value Per Share

¥3.84 - ¥21.34

Total Value Per Share

¥21.41 - ¥38.91

2. Growth of Guangxi Liuzhou Pharm Co Ltd (5 min.)




Is Guangxi Liuzhou Pharm Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$878.4m$801.2m$77.1m8.8%

How much money is Guangxi Liuzhou Pharm Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$96.8m$77.8m$19m19.6%
Net Profit Margin3.7%3.3%--

How much money comes from the company's main activities?

3. Financial Health of Guangxi Liuzhou Pharm Co Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  


Richest
#12 / 41

Most Revenue
#11 / 41

Most Profit
#10 / 41

What can you expect buying and holding a share of Guangxi Liuzhou Pharm Co Ltd? (5 min.)

Welcome investor! Guangxi Liuzhou Pharm Co Ltd's management wants to use your money to grow the business. In return you get a share of Guangxi Liuzhou Pharm Co Ltd.

What can you expect buying and holding a share of Guangxi Liuzhou Pharm Co Ltd?

First you should know what it really means to hold a share of Guangxi Liuzhou Pharm Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Guangxi Liuzhou Pharm Co Ltd is ¥22.89. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guangxi Liuzhou Pharm Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guangxi Liuzhou Pharm Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥17.57. Based on the TTM, the Book Value Change Per Share is ¥1.55 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.96 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guangxi Liuzhou Pharm Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.271.2%0.271.2%0.210.9%0.241.1%0.170.7%
Usd Book Value Change Per Share0.210.9%0.210.9%0.140.6%0.210.9%0.231.0%
Usd Dividend Per Share0.130.6%0.130.6%0.130.6%0.120.5%0.070.3%
Usd Total Gains Per Share0.351.5%0.351.5%0.271.2%0.331.4%0.301.3%
Usd Price Per Share2.58-2.58-2.63-3.29-5.39-
Price to Earnings Ratio9.64-9.64-12.24-13.73-47.22-
Price-to-Total Gains Ratio7.45-7.45-9.69-10.29-28.89-
Price to Book Ratio1.06-1.06-1.19-1.73-6.29-
Price-to-Total Gains Ratio7.45-7.45-9.69-10.29-28.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.15882
Number of shares316
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.130.12
Usd Book Value Change Per Share0.210.21
Usd Total Gains Per Share0.350.33
Gains per Quarter (316 shares)109.29103.82
Gains per Year (316 shares)437.17415.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1167270427145270405
2334540864291540820
350181113014368091235
46681081173858210791650
58351351217572713492065
610021621261287316192480
7116818923049101818892895
8133521623486116421593310
9150224323923130924283725
10166927024360145426984140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%

Fundamentals of Guangxi Liuzhou Pharm Co Ltd

About Guangxi Liuzhou Pharm Co Ltd

Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It also offers smart medicine value-added services. The company was founded in 1981 and is based in Liuzhou, China.

Fundamental data was last updated by Penke on 2024-04-18 12:33:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Guangxi Liuzhou Pharm Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Guangxi Liuzhou Pharm Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 3.7% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 3.7%. The company is making a profit. +1
  • The TTM is 3.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.7%TTM3.7%0.0%
TTM3.7%YOY3.3%+0.4%
TTM3.7%5Y4.1%-0.4%
5Y4.1%10Y3.9%+0.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%2.0%+1.7%
TTM3.7%2.1%+1.6%
YOY3.3%2.5%+0.8%
5Y4.1%2.2%+1.9%
10Y3.9%2.1%+1.8%
1.1.2. Return on Assets

Shows how efficient Guangxi Liuzhou Pharm Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • 3.8% Return on Assets means that Guangxi Liuzhou Pharm Co Ltd generated ¥0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 3.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.8%TTM3.8%0.0%
TTM3.8%YOY3.6%+0.2%
TTM3.8%5Y4.7%-0.9%
5Y4.7%10Y4.9%-0.2%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8%0.9%+2.9%
TTM3.8%0.9%+2.9%
YOY3.6%1.2%+2.4%
5Y4.7%1.0%+3.7%
10Y4.9%1.1%+3.8%
1.1.3. Return on Equity

Shows how efficient Guangxi Liuzhou Pharm Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • 11.8% Return on Equity means Guangxi Liuzhou Pharm Co Ltd generated ¥0.12 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 11.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.8%TTM11.8%0.0%
TTM11.8%YOY10.3%+1.4%
TTM11.8%5Y13.1%-1.3%
5Y13.1%10Y14.7%-1.6%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ11.8%2.4%+9.4%
TTM11.8%2.4%+9.4%
YOY10.3%2.4%+7.9%
5Y13.1%2.4%+10.7%
10Y14.7%2.9%+11.8%

1.2. Operating Efficiency of Guangxi Liuzhou Pharm Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Guangxi Liuzhou Pharm Co Ltd is operating .

  • Measures how much profit Guangxi Liuzhou Pharm Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • An Operating Margin of 5.8% means the company generated ¥0.06  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 5.8%. The company is operating less efficient.
  • The TTM is 5.8%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ5.8%TTM5.8%0.0%
TTM5.8%YOY5.4%+0.3%
TTM5.8%5Y6.2%-0.4%
5Y6.2%10Y4.6%+1.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8%3.3%+2.5%
TTM5.8%2.6%+3.2%
YOY5.4%3.4%+2.0%
5Y6.2%3.4%+2.8%
10Y4.6%3.1%+1.5%
1.2.2. Operating Ratio

Measures how efficient Guangxi Liuzhou Pharm Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.82 means that the operating costs are ¥1.82 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 1.824. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.824. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.824TTM1.8240.000
TTM1.824YOY1.828-0.004
TTM1.8245Y1.820+0.005
5Y1.82010Y1.649+0.171
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8241.618+0.206
TTM1.8241.515+0.309
YOY1.8281.422+0.406
5Y1.8201.246+0.574
10Y1.6491.155+0.494

1.3. Liquidity of Guangxi Liuzhou Pharm Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Guangxi Liuzhou Pharm Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.49 means the company has ¥1.49 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 1.489. The company is just able to pay all its short-term debts.
  • The TTM is 1.489. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.489TTM1.4890.000
TTM1.489YOY1.551-0.062
TTM1.4895Y1.520-0.031
5Y1.52010Y1.259+0.261
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4891.374+0.115
TTM1.4891.398+0.091
YOY1.5511.424+0.127
5Y1.5201.401+0.119
10Y1.2591.350-0.091
1.3.2. Quick Ratio

Measures if Guangxi Liuzhou Pharm Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.80 means the company can pay off ¥0.80 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 0.805. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.805. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.805TTM0.8050.000
TTM0.805YOY0.844-0.040
TTM0.8055Y0.874-0.069
5Y0.87410Y0.872+0.002
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8050.738+0.067
TTM0.8050.751+0.054
YOY0.8440.807+0.037
5Y0.8740.788+0.086
10Y0.8720.855+0.017

1.4. Solvency of Guangxi Liuzhou Pharm Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Guangxi Liuzhou Pharm Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.66 means that Guangxi Liuzhou Pharm Co Ltd assets are financed with 65.8% credit (debt) and the remaining percentage (100% - 65.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 0.658. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.658. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.658TTM0.6580.000
TTM0.658YOY0.634+0.024
TTM0.6585Y0.624+0.034
5Y0.62410Y0.632-0.008
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6580.614+0.044
TTM0.6580.608+0.050
YOY0.6340.600+0.034
5Y0.6240.595+0.029
10Y0.6320.594+0.038
1.4.2. Debt to Equity Ratio

Measures if Guangxi Liuzhou Pharm Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 205.1% means that company has ¥2.05 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 2.051. The company is just not able to pay all its debts with equity.
  • The TTM is 2.051. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.051TTM2.0510.000
TTM2.051YOY1.844+0.207
TTM2.0515Y1.778+0.273
5Y1.77810Y1.980-0.202
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0511.558+0.493
TTM2.0511.630+0.421
YOY1.8441.697+0.147
5Y1.7781.704+0.074
10Y1.9801.760+0.220

2. Market Valuation of Guangxi Liuzhou Pharm Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guangxi Liuzhou Pharm Co Ltd generates.

  • Above 15 is considered overpriced but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • A PE ratio of 9.64 means the investor is paying ¥9.64 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The EOD is 11.819. Based on the earnings, the company is underpriced. +1
  • The MRQ is 9.640. Based on the earnings, the company is underpriced. +1
  • The TTM is 9.640. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD11.819MRQ9.640+2.179
MRQ9.640TTM9.6400.000
TTM9.640YOY12.237-2.597
TTM9.6405Y13.729-4.089
5Y13.72910Y47.221-33.492
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD11.81912.686-0.867
MRQ9.64013.542-3.902
TTM9.64015.843-6.203
YOY12.23718.873-6.636
5Y13.72915.030-1.301
10Y47.22121.329+25.892
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The EOD is 25.658. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 20.928. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 20.928. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD25.658MRQ20.928+4.730
MRQ20.928TTM20.9280.000
TTM20.928YOY100.218-79.290
TTM20.9285Y35.420-14.493
5Y35.42010Y-153.442+188.863
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD25.6586.973+18.685
MRQ20.9289.109+11.819
TTM20.92812.534+8.394
YOY100.2180.763+99.455
5Y35.4203.171+32.249
10Y-153.4424.037-157.479
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Guangxi Liuzhou Pharm Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 1.06 means the investor is paying ¥1.06 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The EOD is 1.303. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.062. Based on the equity, the company is underpriced. +1
  • The TTM is 1.062. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.303MRQ1.062+0.240
MRQ1.062TTM1.0620.000
TTM1.062YOY1.188-0.126
TTM1.0625Y1.731-0.668
5Y1.73110Y6.286-4.555
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD1.3030.988+0.315
MRQ1.0621.119-0.057
TTM1.0621.133-0.071
YOY1.1881.303-0.115
5Y1.7311.298+0.433
10Y6.2862.044+4.242
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guangxi Liuzhou Pharm Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.5491.5490%1.011+53%1.547+0%1.653-6%
Book Value Per Share--17.57317.5730%16.023+10%14.522+21%9.977+76%
Current Ratio--1.4891.4890%1.551-4%1.520-2%1.259+18%
Debt To Asset Ratio--0.6580.6580%0.634+4%0.624+5%0.632+4%
Debt To Equity Ratio--2.0512.0510%1.844+11%1.778+15%1.980+4%
Dividend Per Share--0.9570.9570%0.954+0%0.834+15%0.532+80%
Eps--1.9371.9370%1.556+24%1.760+10%1.225+58%
Free Cash Flow Per Share--0.8920.8920%0.190+370%0.391+128%-0.039+104%
Free Cash Flow To Equity Per Share---1.126-1.1260%-0.474-58%1.093-203%0.828-236%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--21.340--------
Intrinsic Value_10Y_min--3.841--------
Intrinsic Value_1Y_max--1.037--------
Intrinsic Value_1Y_min--0.069--------
Intrinsic Value_3Y_max--3.955--------
Intrinsic Value_3Y_min--0.482--------
Intrinsic Value_5Y_max--7.885--------
Intrinsic Value_5Y_min--1.193--------
Market Cap8290620293.760+18%6762798627.0006762798627.0000%6899332991.040-2%8635609283.556-22%14163593577.485-52%
Net Profit Margin--0.0370.0370%0.033+12%0.041-11%0.039-5%
Operating Margin--0.0580.0580%0.054+6%0.062-6%0.046+24%
Operating Ratio--1.8241.8240%1.8280%1.820+0%1.649+11%
Pb Ratio1.303+18%1.0621.0620%1.188-11%1.731-39%6.286-83%
Pe Ratio11.819+18%9.6409.6400%12.237-21%13.729-30%47.221-80%
Price Per Share22.890+18%18.67018.6700%19.040-2%23.818-22%39.086-52%
Price To Free Cash Flow Ratio25.658+18%20.92820.9280%100.218-79%35.420-41%-153.442+833%
Price To Total Gains Ratio9.133+18%7.4497.4490%9.692-23%10.285-28%28.886-74%
Quick Ratio--0.8050.8050%0.844-5%0.874-8%0.872-8%
Return On Assets--0.0380.0380%0.036+6%0.047-19%0.049-22%
Return On Equity--0.1180.1180%0.103+14%0.131-10%0.147-20%
Total Gains Per Share--2.5062.5060%1.964+28%2.381+5%2.185+15%
Usd Book Value--878418011.067878418011.0670%801265241.987+10%726452702.088+21%499043485.421+76%
Usd Book Value Change Per Share--0.2140.2140%0.139+53%0.213+0%0.228-6%
Usd Book Value Per Share--2.4252.4250%2.211+10%2.004+21%1.377+76%
Usd Dividend Per Share--0.1320.1320%0.132+0%0.115+15%0.073+80%
Usd Eps--0.2670.2670%0.215+24%0.243+10%0.169+58%
Usd Free Cash Flow--44595002.31444595002.3140%9500389.862+369%19566603.591+128%-1747117.710+104%
Usd Free Cash Flow Per Share--0.1230.1230%0.026+370%0.054+128%-0.005+104%
Usd Free Cash Flow To Equity Per Share---0.155-0.1550%-0.065-58%0.151-203%0.114-236%
Usd Market Cap1144105600.539+18%933266210.526933266210.5260%952107952.764-2%1191714081.131-22%1954575913.693-52%
Usd Price Per Share3.159+18%2.5762.5760%2.628-2%3.287-22%5.394-52%
Usd Profit--96809520.62296809520.6220%77806798.131+24%88062236.319+10%61280895.622+58%
Usd Revenue--2629290661.5172629290661.5170%2364605600.364+11%2164603749.140+21%1547557706.647+70%
Usd Total Gains Per Share--0.3460.3460%0.271+28%0.329+5%0.302+15%
 EOD+4 -4MRQTTM+0 -0YOY+25 -105Y+20 -1510Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Guangxi Liuzhou Pharm Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.819
Price to Book Ratio (EOD)Between0-11.303
Net Profit Margin (MRQ)Greater than00.037
Operating Margin (MRQ)Greater than00.058
Quick Ratio (MRQ)Greater than10.805
Current Ratio (MRQ)Greater than11.489
Debt to Asset Ratio (MRQ)Less than10.658
Debt to Equity Ratio (MRQ)Less than12.051
Return on Equity (MRQ)Greater than0.150.118
Return on Assets (MRQ)Greater than0.050.038
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Guangxi Liuzhou Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.947
Ma 20Greater thanMa 5020.981
Ma 50Greater thanMa 10020.549
Ma 100Greater thanMa 20019.756
OpenGreater thanClose22.400
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets18,606,992
Total Liabilities12,241,644
Total Stockholder Equity5,968,965
 As reported
Total Liabilities 12,241,644
Total Stockholder Equity+ 5,968,965
Total Assets = 18,606,992

Assets

Total Assets18,606,992
Total Current Assets16,125,160
Long-term Assets2,481,831
Total Current Assets
Cash And Cash Equivalents 3,854,653
Net Receivables 8,712,837
Inventory 2,462,260
Other Current Assets 462,911
Total Current Assets  (as reported)16,125,160
Total Current Assets  (calculated)15,492,660
+/- 632,500
Long-term Assets
Property Plant Equipment 1,202,837
Goodwill 765,460
Intangible Assets 256,501
Long-term Assets Other 127,802
Long-term Assets  (as reported)2,481,831
Long-term Assets  (calculated)2,352,600
+/- 129,232

Liabilities & Shareholders' Equity

Total Current Liabilities10,827,718
Long-term Liabilities1,413,926
Total Stockholder Equity5,968,965
Total Current Liabilities
Short Long Term Debt 2,996,060
Accounts payable 6,526,373
Other Current Liabilities 1,036,903
Total Current Liabilities  (as reported)10,827,718
Total Current Liabilities  (calculated)10,559,336
+/- 268,382
Long-term Liabilities
Long term Debt 967,967
Capital Lease Obligations Min Short Term Debt139,212
Long-term Liabilities Other 233,596
Long-term Liabilities  (as reported)1,413,926
Long-term Liabilities  (calculated)1,340,775
+/- 73,151
Total Stockholder Equity
Retained Earnings 3,235,688
Total Stockholder Equity (as reported)5,968,965
Total Stockholder Equity (calculated)3,235,688
+/- 2,733,276
Other
Capital Stock362,228
Common Stock Shares Outstanding 362,228
Net Debt 109,374
Net Invested Capital 9,932,991
Net Working Capital 5,297,443
Property Plant and Equipment Gross 1,202,837



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
1,573,669
2,029,382
2,697,874
3,735,623
4,304,984
6,278,927
7,554,049
9,772,635
11,958,214
14,807,734
15,874,751
18,606,992
18,606,99215,874,75114,807,73411,958,2149,772,6357,554,0496,278,9274,304,9843,735,6232,697,8742,029,3821,573,669
   > Total Current Assets 
0
0
0
0
3,894,792
5,696,426
6,785,495
8,025,129
10,094,286
12,786,307
13,387,645
16,125,160
16,125,16013,387,64512,786,30710,094,2868,025,1296,785,4955,696,4263,894,7920000
       Cash And Cash Equivalents 
398,558
593,470
668,144
932,279
723,906
1,717,347
1,073,742
1,240,603
1,915,191
3,495,891
3,415,544
3,854,653
3,854,6533,415,5443,495,8911,915,1911,240,6031,073,7421,717,347723,906932,279668,144593,470398,558
       Short-term Investments 
0
0
0
0
0
0
350,000
75,000
0
0
0
0
000075,000350,000000000
       Net Receivables 
755,434
972,459
1,362,089
1,858,448
2,417,317
2,985,734
4,026,210
5,214,918
6,420,386
6,364,288
7,285,456
8,712,837
8,712,8377,285,4566,364,2886,420,3865,214,9184,026,2102,985,7342,417,3171,858,4481,362,089972,459755,434
       Other Current Assets 
42,263
42,712
56,750
72,143
91,127
132,621
209,765
231,304
249,786
252,088
290,524
462,911
462,911290,524252,088249,786231,304209,765132,62191,12772,14356,75042,71242,263
   > Long-term Assets 
0
0
0
0
0
582,501
768,555
1,747,505
1,863,928
2,021,426
2,487,106
2,481,831
2,481,8312,487,1062,021,4261,863,9281,747,505768,555582,50100000
       Property Plant Equipment 
8,808
14,488
70,728
181,616
296,979
371,050
515,776
601,687
687,233
791,224
1,211,788
1,202,837
1,202,8371,211,788791,224687,233601,687515,776371,050296,979181,61670,72814,4888,808
       Goodwill 
0
0
0
0
0
0
0
765,460
765,460
765,460
765,460
765,460
765,460765,460765,460765,460765,4600000000
       Long Term Investments 
0
0
0
0
0
51,716
75,046
75,046
0
0
0
0
000075,04675,04651,71600000
       Intangible Assets 
38,468
42,752
64,177
65,069
83,714
102,021
101,139
141,823
197,554
208,087
226,822
256,501
256,501226,822208,087197,554141,823101,139102,02183,71465,06964,17742,75238,468
       Long-term Assets Other 
0
0
0
0
0
23,410
22,243
60,053
85,021
110,584
139,177
127,802
127,802139,177110,58485,02160,05322,24323,41000000
> Total Liabilities 
1,299,436
1,650,795
2,196,869
2,561,701
2,944,349
3,041,188
3,985,530
5,725,598
7,300,692
9,363,160
10,068,481
12,241,644
12,241,64410,068,4819,363,1607,300,6925,725,5983,985,5303,041,1882,944,3492,561,7012,196,8691,650,7951,299,436
   > Total Current Liabilities 
1,277,551
1,631,230
2,168,451
2,438,109
2,882,425
2,980,202
3,925,713
5,231,575
6,872,726
8,211,639
8,628,846
10,827,718
10,827,7188,628,8468,211,6396,872,7265,231,5753,925,7132,980,2022,882,4252,438,1092,168,4511,631,2301,277,551
       Short-term Debt 
0
0
0
0
0
263,000
623,670
1,323,670
0
0
0
0
00001,323,670623,670263,00000000
       Short Long Term Debt 
0
0
0
0
0
263,000
623,670
1,323,670
1,888,720
2,771,590
2,711,207
2,996,060
2,996,0602,711,2072,771,5901,888,7201,323,670623,670263,00000000
       Accounts payable 
993,090
1,160,583
1,541,652
1,816,322
2,073,854
2,598,606
3,005,867
3,188,677
3,997,041
4,439,216
4,802,780
6,526,373
6,526,3734,802,7804,439,2163,997,0413,188,6773,005,8672,598,6062,073,8541,816,3221,541,6521,160,583993,090
       Other Current Liabilities 
35,961
48,507
31,389
61,898
105,270
62,609
270,118
683,775
922,165
944,737
975,496
1,036,903
1,036,903975,496944,737922,165683,775270,11862,609105,27061,89831,38948,50735,961
   > Long-term Liabilities 
0
0
0
0
0
60,985
59,817
494,023
427,966
1,151,521
1,439,635
1,413,926
1,413,9261,439,6351,151,521427,966494,02359,81760,98500000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-263,000
-623,670
-1,323,670
0
254,634
190,848
139,212
139,212190,848254,6340-1,323,670-623,670-263,00000000
       Long-term Liabilities Other 
0
0
0
0
0
6,885
6,885
6,885
7,864
229,712
232,219
233,596
233,596232,219229,7127,8646,8856,8856,88500000
       Deferred Long Term Liability 
0
0
0
0
6,994
17,355
34,144
72,577
90,441
96,002
91,526
0
091,52696,00290,44172,57734,14417,3556,9940000
> Total Stockholder Equity
274,233
378,587
501,005
1,155,646
1,329,149
3,190,022
3,491,758
3,846,463
4,372,782
5,098,596
5,460,085
5,968,965
5,968,9655,460,0855,098,5964,372,7823,846,4633,491,7583,190,0221,329,1491,155,646501,005378,587274,233
   Common Stock
90,000
90,000
90,000
112,500
112,500
142,348
185,052
259,073
259,073
362,664
362,360
0
0362,360362,664259,073259,073185,052142,348112,500112,50090,00090,00090,000
   Retained Earnings 
90,870
186,358
297,667
449,271
622,774
858,377
1,160,113
1,566,164
2,092,877
2,628,438
2,974,795
3,235,688
3,235,6882,974,7952,628,4382,092,8771,566,1641,160,113858,377622,774449,271297,667186,35890,870
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
152,870
152,866
0
0152,866152,870000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue20,447,073
Cost of Revenue-18,077,250
Gross Profit2,369,8242,369,824
 
Operating Income (+$)
Gross Profit2,369,824
Operating Expense-19,173,896
Operating Income1,273,177-16,804,072
 
Operating Expense (+$)
Research Development30,748
Selling General Administrative649,286
Selling And Marketing Expenses-
Operating Expense19,173,896680,034
 
Net Interest Income (+$)
Interest Income69,470
Interest Expense-282,936
Other Finance Cost-14,212
Net Interest Income-199,255
 
Pretax Income (+$)
Operating Income1,273,177
Net Interest Income-199,255
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,026,8971,273,177
EBIT - interestExpense = -282,936
800,817
1,083,753
Interest Expense282,936
Earnings Before Interest and Taxes (EBIT)-1,309,833
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,026,897
Tax Provision-154,422
Net Income From Continuing Ops872,474872,474
Net Income800,817
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-199,255
 

Technical Analysis of Guangxi Liuzhou Pharm Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guangxi Liuzhou Pharm Co Ltd. The general trend of Guangxi Liuzhou Pharm Co Ltd is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guangxi Liuzhou Pharm Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangxi Liuzhou Pharm Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 22.55 < 23.64 < 25.22.

The bearish price targets are: 22.20 > 19.77 > 19.74.

Tweet this
Guangxi Liuzhou Pharm Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangxi Liuzhou Pharm Co Ltd. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangxi Liuzhou Pharm Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangxi Liuzhou Pharm Co Ltd. The current macd is 0.37615479.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Guangxi Liuzhou Pharm Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Guangxi Liuzhou Pharm Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Guangxi Liuzhou Pharm Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Guangxi Liuzhou Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuangxi Liuzhou Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangxi Liuzhou Pharm Co Ltd. The current adx is 27.13.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Guangxi Liuzhou Pharm Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Guangxi Liuzhou Pharm Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangxi Liuzhou Pharm Co Ltd. The current sar is 20.91.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Guangxi Liuzhou Pharm Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangxi Liuzhou Pharm Co Ltd. The current rsi is 72.95. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Guangxi Liuzhou Pharm Co Ltd Daily Relative Strength Index (RSI) ChartGuangxi Liuzhou Pharm Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangxi Liuzhou Pharm Co Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Guangxi Liuzhou Pharm Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Guangxi Liuzhou Pharm Co Ltd Daily Stochastic Oscillator ChartGuangxi Liuzhou Pharm Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangxi Liuzhou Pharm Co Ltd. The current cci is 232.03.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Guangxi Liuzhou Pharm Co Ltd Daily Commodity Channel Index (CCI) ChartGuangxi Liuzhou Pharm Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangxi Liuzhou Pharm Co Ltd. The current cmo is 60.33.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Guangxi Liuzhou Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuangxi Liuzhou Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangxi Liuzhou Pharm Co Ltd. The current willr is -10.08645533.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Guangxi Liuzhou Pharm Co Ltd Daily Williams %R ChartGuangxi Liuzhou Pharm Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangxi Liuzhou Pharm Co Ltd.

Guangxi Liuzhou Pharm Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangxi Liuzhou Pharm Co Ltd. The current atr is 0.66561597.

Guangxi Liuzhou Pharm Co Ltd Daily Average True Range (ATR) ChartGuangxi Liuzhou Pharm Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangxi Liuzhou Pharm Co Ltd. The current obv is 170,891,630.

Guangxi Liuzhou Pharm Co Ltd Daily On-Balance Volume (OBV) ChartGuangxi Liuzhou Pharm Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangxi Liuzhou Pharm Co Ltd. The current mfi is 79.10.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Guangxi Liuzhou Pharm Co Ltd Daily Money Flow Index (MFI) ChartGuangxi Liuzhou Pharm Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangxi Liuzhou Pharm Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Guangxi Liuzhou Pharm Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangxi Liuzhou Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.947
Ma 20Greater thanMa 5020.981
Ma 50Greater thanMa 10020.549
Ma 100Greater thanMa 20019.756
OpenGreater thanClose22.400
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Guangxi Liuzhou Pharm Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Guangxi Liuzhou Pharm Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guangxi Liuzhou Pharm Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangxi Liuzhou Pharm Co Ltd

I send you an email if I find something interesting about Guangxi Liuzhou Pharm Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guangxi Liuzhou Pharm Co Ltd.

Receive notifications about Guangxi Liuzhou Pharm Co Ltd in your mailbox!